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Chemically modified allergens may be useful immunotherapeutic reagents in man. 
What  is  required  of such  reagents  is  that  the  modified  allergens  show  reduced 
allergenic activities yet retain the immunosuppressive properties of the native mole- 
cule. It is with this objective that we have prepared conjugates of antigen E with two 
polymers of large  molecular weights.  Antigen  E  is  the  major allergen  of ragweed 
pollen  and  it  is  an  acidic  protein  of ~38,000  daltons  (1).  The  two  polymers  are 
methoxypolyethylene glycol  (MPEG) 1 of  ~5,000  daltons  and  a  copolymer of D- 
glutamie acid and  D-lysine (DGL)  of ~34,000  daltons.  MPEG was chosen because 
MPEG protein conjugates are known to have reduced allergenic and immunogenic 
activities  (2,  3).  DGL  was  chosen  because  DGL  conjugates  with  haptens  of low 
molecular weight are known to possess hapten-specific immunosuppressive properties 
(4,  5). To study the influence of the bulky MPEG groups on the immunochemical 
properties of the conjugate, we also prepared a conjugate using methanol in place of 
MPEG. 
In  this paper we report comparative studies on the immunological properties of 
antigen  E  and  its conjugates in the mouse as the experimental animal.  The mouse 
system was chosen since it is generally accepted that the IgE response in this system 
is the best model for reaginic antibody formation in man  (6).  MPEG and methoxy 
antigen E conjugates were prepared by coupling the protein with cyanuric chloride 
activated MPEG  (2) or methanol  (7) as shown in Fig.  1. DGL antigen E  conjugate 
was prepared via an intermolecular disulfide bond formation (8). As shown in Fig. 2, 
antigen E and DGL were first modified to contain reactive thiol and 4-dithiopyridyl 
groups, then they were coupled via these groups. 
Materials and Methods 
Materials.  Antigen E  was isolated from ragweed pollen as described (9);  its isoelectric forms B 
and C were used interehangeably in this study. MPEG of average mol wt of 5,000 was a gift of 
Union Carbide Corp., New York. A random copolymer of DGL in a molar ratio of 6:4, having 
an average mol wt of 34,000, was a gift from Miles Laboratories Inc., Miles Research Products, 
Elkhart, Ind. 
* Supported in part by grant AI-14422 and contract NO 1 AI 82567  of the National Institutes of Health. 
i Abbreviations used in this paper: BPO, benzyl-penicilloyl; DGL, D-glutamic acid and D lysine; HA, passive 
agglutination; MPEG, methoxypolyethylene glycol; PCA, passive cutaneous anaphylaxis, PEG, polyethyl- 
ene glycol. 
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FIc. I.  Scheme for  preparation of  methoxypolyethylene  glycol  or  methoxy conjugate of  antigen E. 
For the sample of MPEG of 5,000 daltons used,  n is equal to 114. For the methoxy conjugate n is 
zero.  Antigen  E  has  a  tool wt of =38,000  dahons.  The conjugates prepared  contained  about  6 
MPEG or methoxy groups  per mole of antigen E. 
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FxG. 2.  Scheme for preparation of conjugate of antigen E with a copolymer of DGL  of 34,000 
dahons. The conjugate prepared is  believed  to  have the composition of  [DGLL~AgEx]n when n is  in 
the range  of I-3. The number  x of intermolecular disulfide  bonds in the conjugate was not 
determined. 
MPEG-Antigen E  Conjugate.  Two samples,  a  and  b,  of this  conjugate were prepared  with 
MPEG activated with cyanuric chloride under different conditions. One condition used was a 
modification of that reported (2), namely, the reaction medium benzene contained  1.3% water. 
Microanalysis  showed  the  activated  MPEG  to  contain  0.58%  chlorine.  MPEG-antigen  E 
conjugate  (sample  a)  was  prepared  by  coupling  antigen  E  (0.1  raM,  3.8  mg  per  ml)  and 
activated MPEG (20 mM,  100 mg per ml) in 25 mM sodium borax buffer (pH 9; 20 ml) for 18 
h at room temperature  (r.t.). The conjugate was isolated by chromatography on a column (195 
x  2.6 cm) of Sephacryl  (Pharmaeia  Fine Chemicals Inc., Piscataway,  N. J.), which was eluted 
with 0.1  M  NH4HCO3 at a  flow rate of ~34 ml per hour. The conjugate was eluted near the 
column void volume (380-490  ml)  and  the unreacted  MPEG and  the antigen E  were eluted 
together as a  broad peak with its maximum at ~650 ml. Amino acid analysis of the conjugate 
after acid hydrolysis  (10)  showed that  its antigen E  content was 55 mg (72% yield). Its lysine 
content was 12.3  -4- 0.7 residues per mole as compared to that of 18 residues per mole for native 
antigen (11).  The lysine content suggests a minimum of six MPEG groups per mole of conjugate 
because N,~-(2 hydroxy-4-MPEG-6-triazinyl)-lysine is partially converted back to lysine during 
acid hydrolysis (3). On electrophoresis of the conjugate in SDS-4% polyacrylamide gel (12,  13), 
two broad  bands  were observed. A  minor band  was located near the origin of the gel and  its 426  RAGWEED POLLEN ANTIGEN E 
mobility would correspond to a molecule of a size >  that of bovine plasma albumin decamer 
(670,000 daltons). A major band migrated as a broad zone in the mobility range of albumin 
dimer to pentamer, but the majority was in the range of trimer and tetramer (201,000-268,000 
dahons). 
Sample b  of MPEG-antigen E  conjugate was  obtained by using MPEG activated by a 
different method. MPEG (10 g, 2 mmol) and cyanuric chloride (8.6 g, 46 mmol) were allowed 
to react in a mixture of anhydrous benzene (300 ml) and sodium hydride (0.29 g, 12 mmol) for 
18 h  at  r.t.  Microanalysis of the activated MPEG showed  its chlorine content to be 0.29% 
(calculated  for  C2a2H459Ol14N~I2:C1, 1.37%). Sample  b  conjugate  prepared  with  MPEG 
activated by the sodium hydride method contained 14 residues of lysine per mole and it was 
eluted slightly later from Sephacryl column than the sample a conjugate described above. On 
SDS  gel  electrophoresis, this conjugate migrated as  a  broad zone in the mobility region of 
albumin monomer to tetramer, but the majority was in the dimer to trimer region. 
2-Hydroxy-4-Methoxy-6-Triazinyl-Antigen  E.  The  conjugate was  prepared  on  treatment  of 
antigen E (0.12 mM) with 2,4-dichloro-6-methoxy-triazine  (12 mM) (7) in sodium borax buffer 
(25 mM, pH 9) containing  2.5% dimethoxyethane at r.t. for 18 h. One of the two chloro groups 
of the triazine compound reacted with the amino groups of antigen E,  while the other was 
hydrolyzed during the reaction, as indicated by the consumption of NaOH to keep pH constant. 
The conjugate was isolated by chromatography of reaction mxiture (3 ml) on a column (200 
×  0.9 cm) of Sephadex G-100, which was eluted with 0.1  M  NH4HCO3.  The conjugate was 
obtained in polymeric and monomeric forms having a  similar lysine content of 13.2  ±  1.2 
residues per mole. The polymeric conjugate was eluted at the void volume of the column and 
the monomeric conjugate eluted at the same position as that of native antigen E in yields of 45 
and 40%, respectively.  On electrophoresis in 7.5% polyacrylamide gel  in Tris-glycine buffer 
(14), the monomeric conjugate migrated as a broad diffuse zone having average mobility about 
twice that of native antigen E. Only the monomeric conjugate was studied for its immunological 
properties. 
DGL-Antigen E Conjugate.  DGL was converted to 4-(4'-dithiopyridyl)-butyrimidinyt-DGL  as 
described (8) and the derivative contained about four reactive mixed disulfide groups per mole 
of DGL. Antigen E  (0.18 mM) was converted into its 4-mercaptobutyrimidinyl  derivative by 
reaction with 2-iminothiolane (190 mM) in sodium borax buffer (25 mM; pH 9.0) at r.t.  for 2 
h; the amidinated antigen E  (80% yield) contained about 2.5 sulfhydryl groups per mole on 
titration with 4,4'-dithiodipyridine (8). 
DGL-antigen E conjugate was prepared by reaction of 4-mercaptobutyrimidinyl  antigen E 
(63 ~M)  with 4-(4'-dithiopyridyl)-butyrimidinyl  DGL (124 ~M)  in sodium phosphate buffer 
(0.1 M; pH 7.2) containing EDTA (1 mM). After 18 h at r.t.,  the reaction mixture (3 ml) was 
passed through a  200 x 0.9 cm column of Sephadex G-100 which was eluted with the same 
phosphate buffer. The conjugate (75% yield) was eluted at the void volume of the column (50 
ml), while unreacted antigen E was eluted at --82 ml vol. Chromatography on CL-6B Sepharose 
showed the conjugate to be free of unreacted DGL. The conjugate was found to contain antigen 
E and DGL in a molar ratio of about 1:1.2 on amino acid analysis. On eleetrophoresis in SDS- 
4% polyacrylamide gel, the conjugate migrated as a very broad zone extending from the origin 
of the gel to the position of monomeric bovine plasma albumin. 
Methods.  Immunogenicity  or immunosuppression  studies were made in (BALB/c ×  A/J)F1 
hybrid mice which  are  known to be high responders to  ragweed  antigens (16). Mice were 
immunized intraperitoneally  with 1/~g antigen E and 1 mg alum (17) in 0.2 ml of 0.15 N NaC1 
containing 5  mM  sodium phosphate  (pH  6.6).  For immunosuppression studies,  mice were 
treated subcutaneously with antigen E or its conjugate in 0.2-0.4 ml of 0.15 NaCI containing 
5 mM phosphate (pH 7.2); the amounts used and the times of treatment are given in Tables I 
and  II.  Mice  were  bled  weekly  or  biweekly and  the  collected  sera  were  usually assayed 
immediately or stored frozen until assayed. 
For antibody assay,  twofold serial dilutions of the sera with phosphate-buffered saline (pH 
7.2) containing  0.05% bovine plasma albumin  were made. For antigen E-specific IgG antibodies, 
assays were made with passive agglutination (HA)  of antigen E coated erythrocytes (15). To 
determine the contribution of specific  IgM antibodies, agglutination assays  were also  made 
with sera dilutions which had been treated with 0.1 M mercaptoethanol at r.t. for 1 h (18). The 
contribution of IgM antibodies was found to be significant only in the first 2 wk after primary 
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TABLE  I 
IgE Antibody Levels of AgE Sensitzzed Mice on Treatment with AgE or its Conjugates  ~ 
427 
Group 
Time of PCA titer 
2  4  6  8  I0  12  14  16  18  20  22  28 
Treated with AgE: 
A 
B 
C 
D 
E 
F 
G 
H 
Treated with MPEG-AgE: 
I  20  3 and 4  <5  <5  60 
J  40  3 and 4  <5  <5  <5 
K  140  4 and 6  <5  <5  20 
L  200  3 and 4  <5  <5  40 
M  140  21 and 23  640  I l0  20 
N  200  21  320  110  160  160 
0  1,400  21 and 23  110  40  40  160 
P  140  49 and 51 
Q  1,400  49 and 51 
Treated with DGL-AgE: 
R  100  4 and 6  <5  20  40 
S  100  21 and 23  450  320  80 
T  1,000  21 and 23  640  80  40 
wk 
0  640  320  760  640  1,280  1.520  640  900  900  1.280  1,280  320 
20  3 and 4  40  40  900  320  1,280  640 
200  3 and 4  10  <5  230  80  230  160 
140  21 and 23  640  270  160  230  320  160  160  130  320  160 
200  21  450  160  t60  80  320  230 
1,400  21 and 23  80  80  80  130  80  80  40  200  80 
140  49 and 51  1,280  1,280  320  640  640  640  640  160 
1.400  49 and 51  450  640  640  320  450  320  320  640  80 
30  640  320  I10  80 
<5  110  80  80  40 
10  110  80  40  160 
I0  80  80  80  80 
40  230  80  40  110 
320  160  320 
160  60  40 
160  160  160  80 
90  320  160  80 
70  320  160  80 
1,500  1,280  1,280  900  900  1,280  640  640  160 
760  320  640  450  450  450  640  320  80 
40  230  320  80  160  230  640  230  160 
80  450  640  320  320  320  320  320  160 
80  230  160  40  110  110  320  230  80 
* Mice (BALB/c  ×  A/J)FI hybrids were immunized intraperitoneally with  1/~g antigen E and 0.2 mg alum each time at weeks 0, 4, 8, and 
18. The amounts of conjugate used for treatment refer only to the protein portion of the molecule; the doses  were given subcutaneously. 
:[: Antigen  E-specific lgE antibody  titers were determined by  I~A reactions as described in Materials and Methods.  The majority  (80%) of 
reported  titers are geometric means of duplicate or triplicate analyses, and  the titers seldom  varied by  more than one dilution on  repeat 
assays. 
TAnLE II 
IgG Antibody Levels of AgE Sensitized Mice on Treatment with AgE or its Conjugates 
Group 
Time of HA titer 
2  4  6  8  lO  12  14  16  18  20  22  28 
tag 
Treated with AgE: 
A 
B 
C 
D 
E 
F 
G 
H 
days  wk 
0  40  250  6,400  5.100  I 1,000  .'  8,910  4,500  6,400  6,400  6.400  3,700  2.600 
20  3 and 4  30  110  2,500  2,300  4.500  3,200 
200  3 and 4  40  160  3,200  2,500  1,600  1,600 
140  21 and 23  40  6,400  6,400  6,400  6,400  3.200  3,200  930  1,600 
200  21  40  1,300  1,600  3,200  3,200  1,600 
1,4.00  21 and 23  2,900  5.080  4,500  4,500  3,200  1,600  1,600  1,000 
140  49 and 51  12,800  12,800  9,000  5.700  3,200  3,200  3,200  3,200  3.200 
1.400  49 and 51  16,000  9,000  9,000  6,400  3,200  3,200  3,200  3,200  1,600 
Treated with MPEG-AgE: 
I  20  3 and 4  25  25  2,500  2,300  1,300  3,200  800  1,600 
J  40  3 and 4  5  25  2,500  3,200  1,100  1,600  800  1,600 
K  140  4 and 6  25  160  3,600  1,600  7,000  3,400  1,600  3,200  1,600  3,200  1,900  2,300 
L  200  3 and 4  10  10  1,100  800  400  800  800  800 
M  140  21 and 23  40  5,100  3,200  3,200  5,100  3,200  1,100  1,600  1,600  1,600  1,600 
N  200  21  5,400  5,400  3,200  1,600  1,600  1,600 
O  1,400  21 and 23  1,000  940  800  560  800  400  250  250  800  l,i00  1,1(30 
P  140  49 and 51  6,400  12,800  10,100  5,100  6,400  6,400  3,200  3,200  1,600 
Q  1,400  49 and 51  8,100  17,400  10,000  10,100  6,400  6,400  3,200  2,300  3,200 
Treated with DGL-AgE: 
R  100  4 and 6  50  800  6,400  3,200  4,700  3,200  2,000  1,600  3,200  3,200  940  940 
S  100  21 and  13  40  6,400  6,400  7,100  9,000  4,000  5,200  800  1,610  2,300  1,610 
T  1,000  21 and 23  80  6,400  2,500  4,700  4,500  2,000  1,600  3,200  3,200  2,300  1,100 
* Same as *, Table I. 
Antigen E-specific IgG antibodies were determined by agglutination tests as described in Materials and Methods. The majority of reported 
tlters are geometric means of duplieate or triplicate analyses, and the titers seldom varied by greater than one dilution on repeat assays. 428  RAGWEED POLLEN ANTIGEN E 
For antigen E-specific IgE antibodies, assays were made using passive cutaneous anaphylaxis 
(PCA) in retired male breeder rats (19, 20). Twofold serial dilutions of mouse sera (0.10 ml per 
site) were injected intradermally into separate sites on the shaved dorsal skin of the rat. After 
a 4-16-h incubation period, the rat was challenged intravenously with  1.5 ml of phosphate- 
buffered saline  containing antigen E  (0.4 rag)  and  Evans blue  (7.5 mg). The IgE antibody 
content was recorded as the reciprocal of the highest  serum dilution  giving  a  5 ram bluing 
reaction 15 rain after antigen reaction. 
Under the conditions used, an agglutination titer of 100 is estimated to be equivalent to ~ 10 
/~g per ml of IgG antibody (15), and a PCA titer of 100 is equivalent to ~10 ng per ml of IgE 
antibody (21). 
Allergenic  activity of conjugates was studied as follows. Separate skin sites of a shaved rat 
were sensitized  with 0.10-ml  aliquots of 1/50 diluted mouse anti-antigen E sera, which was 
found to have a  PCA titer of 640. 4 h later the rat was given 1.5 ml of Evans blue solution 
intravenously. The sensitized  sites were then challenged locally with serial threefold dilutions 
of test antigen in a 0.05-ml vol. The lowest antigen dilution which gave a 5-ram bluing reaction 
5 rain after injection  is taken as the end-point. Antigenic activity of conjugates was studied by 
inhibition of agglutination of antigen E-coated erythrocytes with specific rabbit antisera (3, 
15). 
Results 
The conjugates inhibited  the agglutination of antigen  E-coated erythrocytes with 
antigen  E-specific rabbit  antibodies.  Under  the conditions  used,  the concentrations 
required  for inhibition were 0.25 #g per ml for antigen  E, 25  and 2.5/zg per ml for 
samples a  and b  of MPEG-antigen E, 0.5/~g per ml for methoxy-antigen E, and 2.5 
#g per ml for DGL-antigen E. Therefore, the antigenic activities of MPEG, methoxy, 
and DGL conjugates are, respecitvely, 10-100, 2 and  10-fold less active than antigen 
E. Samples a  and b  of MPEG-antigen E  differ chemically in the number of MPEG 
groups introduced. 
The conjugates also showed reduced activities when tested by heterologous PCA on 
rats sensitized with antigen E-specific mouse IgE antibodies (=0.12 ng per site). Under 
the  conditions  used,  PCA  reactions  were  observed  when  the  sensitized  sites  were 
challenged  with  0.05  ml of 0.5  ng per  ml of antigen  E,  400  and  40  ng per  ml of 
samples a  and b  of MPEG-antigen E, 0.5  ng per ml of methoxy-antigen E  or  14 ng 
per ml of DGL-antigen E. On a  relative basis, the allergenic activities of MPEG and 
DGL  conjugates  are,  respectively,  about  80-800  and  nine  times  less  active  than 
antigen E, while the methoxy conjugate is equally as active as antigen E. 
When mice, which are high responders to ragweed antigens (16), were immunized 
with antigen E  (1/zg) with alum as adjuvant, high titers of antigen E-specific IgE and 
IgG antibodies  were  readily obtained  by weeks  2  and  4,  respectively,  (group  A  in 
Tables I and II). Under identical conditions, mice immunized with MPEG-antigen E 
conjugate (,1/zg of antigen E equivalent)  gave no detectable antibody response. Also, 
the MPEG-antigen E conjugate did not prime the mice for a secondary response when 
they were challenged with antigen E and alum by week 8. 
Comparative studies were made on the effectiveness of antigen E and its MPEG or 
DGL conjugates to suppress antigen E specific antibody responses in mice. Groups of 
three mice were primed intraperitoneally with antigen E  (1/~g)  and alum at week 0 
and boosted at weeks 4, 8,  and  18.  They were treated subcutaneously with varying 
amounts of antigen E  or conjugates  (20-700/zg of antigen E  equivalent), either as a 
single dose or two equal doses at different time periods. In Tables I and II are given, 
respectively, the antigen  E-specific IgE and IgG antibody levels of the control and 
treated groups at biweekly intervals. HA 
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FIG.  3.  Immunosuppression of antigen E sensitized mice on treatment with antigen E. Mice were 
sensitized intraperitoneally on day 0 with antigen E  (0.026  nmol) and alum, then treated subcut- 
naeously on days 21  and 24 with antigen E, a total of 3.6 and 36 nmol, respectively, for groups D 
and F. Group A  is the untreated control group. All groups were rechallenged with antigen E  on 
weeks 4,  8,  and  18.  HA  and  PCA denote titers of antigen  E-specific IgG  and  IgE  antibodies, 
respectively. 
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The data. for control group A, groups D  and F  treated with  140 and  1,400 #g of 
antigen E, and groups M  and O  treated with  140 and  1,400 #g of MPEG-antigen E, 
are also shown in Figs. 3 and 4. The treated groups were given the immunosuppressive 
agent during week 3 when the mice had high levels of IgE antibodies but low levels 
of IgG antibodies from their primary response. After boosting at week 4, the treated 
groups did not show a  secondary response of IgE antibodies, but the control group 
did. After further boostings at weeks 8 and 18, the treated groups did show secondary 
responses of IgE  antibodies.  Before boosting at  weeks  8  and  18,  the IgE antibody 
levels of treated groups were --one tenth of that of the control group. At the peak of 
secondary responses at weeks 10 and 20 the IgE antibody levels of treated groups were 
=one fifth of that of the control group. At week 28, the IgE antibody levels of treated 
groups were still --one fourth of that of the control group. 
In  addition  to  changes  in  IgE  antibody  levels,  the  treated  groups  also  showed 
reduced IgG antibody levels when compared to the control group (Figs.  3 and 4). It 
is evident from the figures that both the kinetics and the magnitude of IgG antibody 
response in mice are different from those of the IgE antibody response. The control 
and  the  treated  groups  did  not  show any secondary IgG antibody responses after 
boosting at weeks 4 and 8.  The treated groups did show a  secondary IgG antibody 
response after the third boost at week  18, but the control group did not. Groups D 
and  F,  treated,  respectively, with  140  and  1,400  #g  of antigen  E,  showed  similar 
degrees of suppression of IgG antibody response, their levels at weeks 18 and 22 being 
~one fourth and one fifth, respectively, of that of the control group. Group M, treated 430 
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F[o.  4.  Immunosuppression  of antigen E sensitized mice upon treatment with MPEG antigen E. 
Group A is the same control group as in Fig.  3. Groups M  and O were treated twice with a total of 
3.6 and 36 nmol of conjugate, respectively.  All other conditions are the same as those shown in Fig, 
3. 
with  140/~g of MPEG-antigen  E  conjugate,  showed similar suppression to those of 
groups  D  and  F.  But  group  O,  treated  with  1,400/~g  of the  conjugate,  showed  a 
stronger suppression, its IgG antibody levels at weeks 18 and 22 being --one thirtieth 
and one fifth, respectively, of that of the control group. 
Treatment of mice with  antigen  E  or the conjugates  was also done within  1 wk 
after priming with antigen E at a time when the mice had no detectable levels of IgE 
or IgG antibodies. Under these conditions, MPEG-antigen E was found to be a more 
effective immunosuppressive agent than antigen E. This conclusion follows from the 
data  in Tables I  and  II for groups B  and  I  which  had been treated with  20 #g of 
antigen E  or its MPEG conjugate, respectively. At week 4 the IgE antibody levels of 
groups B and I were, respectively, one eighth and <one sixtieth of that of the control 
group  A.  At week 4  the  IgG antibody  levels of groups  B  and  I  were,  respectively, 
~one fifth and one tenth of that of the control group A. 
The data in Tables I and II also indicate the dose dependent  nature of immuno- 
suppression. This is seen by comparing the data for groups B and C  treated with 20 
and 200/~g of antigen E, and for groups I, J, and L  treated with 20, 40, and 200/~g 
of MPEG-antigen  E. The data would indicate that  20 ~g of tolerogen per mouse is 
about the minimal amount required to attain near maximal suppression of IgE and 
IgG antibody responses. 
Treatment  of mice with  antigen  E  or  the  conjugates  was  also  done  7  wk  after 
priming with antigen when the mice had high levels of both IgE and IgG antibodies. 
Under  these conditions  weak suppression  of IgE and  IgG antibodies  was observed, 
probably at best half the levels of the control group. This is seen by comparing the 
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E or its MPEG conjugate, respectively, or for groups H  and Q  which received 1,400 
/~g of the immunosuppressive agent, with those of control group A. 
For the data given in the Tables, groups I, J, L, and N were treated with sample a 
of MPEG-antigen E, while groups K, M, O, P, and Q  were treated with sample b of 
this conjugate. Groups K  and L were treated under nearly identical conditions with 
samples  a  and b  of MPEG-antigen  E, which is also the case for groups M  and N. 
Very similar degrees of suppression were obtained with these two samples of MPEG- 
antigen E. 
DGL-antigen  E  appears  to be slightly less  effective in  immunosuppression  than 
MPEG-antigen E, as seen when comparing the data in Tables I and II. When both 
conjugates were administered under similar conditions, groups K, M, and O  treated 
with MPEG-antigen E showed slightly stronger immunosuppression than groups R, 
S, and T  treated with DGL-antigen E, and the difference is probably twofold. 
Discussion 
As reported above, treatment of antigen E primed mice with antigen E, its MPEG 
or DGL conjugates is effective in suppressing antigen E-specific IgE and IgG antibody 
responses.  The  suppression  is  long  lasting,  but  it  is  weakened  after two  or  more 
challenges with the immunogen. The degree of suppression attained is dependent on 
the immune state of mice at the time of treatment, the particular immunosuppressive 
agent  and  the  dose.  The best  suppression  of antibody response was  observed with 
mice which had no detectable antibodies at that time of treatment, while the weakest 
suppression was observed with mice which had high levels of antibodies at  time of 
treatment. The data show that the IgE antibody response is more readily suppressed 
on treatment  with  antigen  E  or its conjugates than  IgG antibody response. Under 
favorable conditions, a  dose of treatment agent, which is equivalent to 20 times the 
immunizing dose,  is sufficient to give observable suppression of both IgE and  IgG 
antibodies. The data suggest that MPEG-antigen E is more effective as an immuno- 
suppressive agent than antigen E, and that DGL-antigen E is probably less effective 
than MPEG-antigen E. 
MPEG- or DGL-antigen E conjugates are not only more effective than antigen E 
as an immunosuppressive agent, but  they are also less  allergenic and  less antigenic 
than  antigen  E.  These  changes  in  the  allergenic  and  antigenic  activities  of the 
conjugates indicate a  reduction in their antigenic valency. The allergenic activity of 
an  antigen  depends on the  interaction of multivalent  antigen  with cell-bound IgE 
antibodies leading to the release of chemical mediators of immediate hypersensitivity, 
and univalent fragments are inactive in this regard (22). 
MPEG-antigen  E  is  apparently nonimmunogenic in  mice, nor does it prime the 
animals for a secondary response to antigen E. The apparent loss of immunogenicity 
of MPEG-antigen E  indicates a  reduction in the antigenic valency as well as in the 
antigenic  specificity.  Immunogenicity  of  an  antigen  for  IgE  and  IgG  antibody 
responses is known to require collaboration of T  and B cells, and T  and B cells may 
have specificities for different antigenic determinants (23-25). 
The  reduction  in  antigenic  valency and  specificity of the  MPEG  conjugate  is 
probably a consequence of steric hindrance by the large polymer groups which reduce 
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may be  a  consequence  of conformational changes  of antigen  E  in  the  conjugate, 
because  the  B-cell-specific antigenic  determinants  of antigen  E  are  conformation 
dependent  (26).  However, conformational changes of MPEG-antigen E, if any are 
present,  are  unlikely to  play an  important  role,  because  its chemically analogous 
methoxy conjugate has essentially the same antigenic or allergenic activity as  the 
native antigen. 
The large polymer groups can also reduce the susceptibility of the conjugates to 
proteolysis, because the polymer groups reduce the accessibility of susceptible peptide 
bonds.  For  example,  MPEG  conjugates of asparaginase  show  markedly  increased 
resistance to tryptic digestion when compared to the native enzyme (27). Therefore, 
the antigen E  conjugates may be processed differently from the native antigen by 
macrophages. Since macrophage processing of antigens is known to be of importance 
in immune responses (28), this possible difference of antigen E and its conjugates may 
be important in their different immunosuppressing activities. 
It  is  of interest  to  compare  the  suppression  of IgE  antibody induced by  DGL- 
antigen E  with that  induced by the benzylpenicilloyl DGL conjugate (BPO-DGL) 
(5). Mice, immunized with BPO coupled keyhole limpet hemocyanin and alum at 
weeks 0 and 3, were treated subcutaneously with DGL-BPO (20 nmol of conjugate 
equivalent to 800 nmol of BPO groups) at week 2. Compared to the untreated control 
group there was a greater than 32-fold suppression of anti-BPO IgE antibody at week 
8. In Table I, group T  treated with DGL-AgE (26 nmol of antigen E) under similar 
conditions showed an eightfold suppression of anti-antigen E IgE antibody at week 8 
as compared to the control group A. 
The different degrees of immunosuppression observed with the DGL-antigen E and 
DGL-BPO  conjugates  may  be  a  consequence  of their  different  immunochemical 
properties. One is the possible instability of DGL-antigen E conjugates under in vivo 
conditions owing to  its labile  disulfide linkages. Another is  the  difference in  their 
antigenic structures. The DGL-BPO conjugate contains multiple antigenic determi- 
nants of identical specificity, but  the  DGL-antigen E  conjugate contains multiple 
determinants of different specificities. In addition, the BPO conjugate has a  higher 
epitope  density than  the  antigen  E  conjugate.  Although  the  epitope  densities  of 
antigen E or its DGL conjugate are not known, it is unlikely that a protein antigen of 
38,000  daltons  will  have  more  than  10  determinants.  These  differences  in  the 
immunochemical properties  of DGL-BPO and  DGL-antigen E  conjugates may be 
responsible for their different cellular mechanisms of induction of immunosuppression. 
Hapten-DGL conjugates have been reported to induce tolerance primarily at the B- 
cell level (29). 
Another  group  of workers  has  recently reported  the  use  of polyethylene glycol 
(PEG)  conjugates of ragweed proteins  for suppression of IgE antibody response in 
mice (30). Their findings on PEG-ragweed proteins are less extensive than the present 
data on MPEG-antigen E, but they are in general agreement with the present report. 
PEG  has  two  terminal  hydroxyl groups  while  MPEG  has  only one.  Coupling  of 
proteins with activated PEG can in theory give a more complex mixture of conjugates 
than coupling with activated MPEG. 
Other workers have used formaldehyde or glutaraldehyde polymerization of pollen 
proteins to reduce their allergenic activity. These treatments have been applied to 
antigen E  (31), ragweed pollen extract (32, 33), purified rye pollen allergen (34) and TE PIAO KING, LOUCIA KOCHOUMIAN, AND NICHOLAS CHIORAZZI  433 
Timothy  pollen  extract  (35).  Such  treated  pollen  proteins  showed  10  to  100-fold 
reduction in their allergenic activities. In experimental animals, such treated pollen 
proteins retained their ability to induce IgE and IgG antibodies specific for the native 
proteins. Desensitization of allergic patients with such treated pollen proteins induced 
significant increases of allergen-specific IgG antibodies in all cases, but only slight or 
no decrease in allergen specific IgE antibodies  (33, 36, 37). The retention of immu- 
nogenicity by formaldehyde or glutaraldehyde-treated pollen antigens in experimental 
animals and man is in contrast to the apparent nonimmunogenicity of MPEG-antigen 
E in mice. 
Summary 
The major allergen of ragweed pollen, antigen  E, was  modified by coupling its 
amino  acid  groups  with  either methanol,  methoxypolyethylene glycol  (MPEG)  of 
5,000  daltons,  or a  synthetic copolymer of D-glutamic acid  and  D-lysine  (DGL)  of 
34,000  daltons,  all  appropriately  activated.  These  conjugates  were  characterized 
chemically  and  immunologically.  Compared  to  the  native  antigen,  the  methoxy 
conjugate showed little reduction in allergenic activity, but the other two conjugates 
showed strong reductions, as measured by heterologous passive cutaneous anaphylaxis 
in rats sensitized with murine anti-antigen E reaginic sera. The MPEG conjugate was 
apparently  nonimmunogenic  in  mice  known  to  be  high  responders  to  the  native 
antigen.  MPEG and  DGL conjugates retained the immunosuppressive property of 
the native antigen as subcutaneous treatment of antigen E sensitized mice with these 
two conjugates led  to significant long-lasting depression of their antigen  E-specific 
IgE  and  IgG antibody levels. These immunological changes  are believed to result 
from reduction of antigenic valency and specificity upon coupling the bulky molecules 
to the protein antigens. 
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